4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002163
Chief Financial Officer sold 3,084 shares at $5.37 ($16,559)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Financial Officer | 2019-01-14 | Sale | −3,084 | $5.37 | $16,559 | 3,318 | D |
| Open-market sales · 3,084 sh · avg $5.37 · $16,559 | |||||||
Loading xslF345X03/a4.xml…